Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Exploring the role of physical activity and exercise for managing vascular comorbidities in people with multiple sclerosis: A scoping review.

Ewanchuk BW, Gharagozloo M, Peelen E, Pilutti LA.

Mult Scler Relat Disord. 2018 Aug 24;26:19-32. doi: 10.1016/j.msard.2018.08.022. [Epub ahead of print] Review.

PMID:
30216755
2.

Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis.

Dhaeze T, Peelen E, Hombrouck A, Peeters L, Van Wijmeersch B, Lemkens N, Lemkens P, Somers V, Lucas S, Broux B, Stinissen P, Hellings N.

J Immunol. 2015 Aug 1;195(3):832-40. doi: 10.4049/jimmunol.1500759. Epub 2015 Jun 12.

3.

GM-CSF production by CD4+ T cells in MS patients: regulation by regulatory T cells and vitamin D.

Peelen E, Muris AH, Damoiseaux J, Knippenberg S, Broens K, Smolders J, Cohen Tervaert JW, Hupperts R, Thewissen M.

J Neuroimmunol. 2015 Mar 15;280:36-42. doi: 10.1016/j.jneuroim.2015.02.007. Epub 2015 Feb 26.

PMID:
25773153
4.

Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis.

Peelen E, Damoiseaux J, Muris AH, Knippenberg S, Smolders J, Hupperts R, Thewissen M.

Mol Immunol. 2015 Feb;63(2):521-9.

PMID:
25458313
5.

Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.

Smolders J, Peelen E, Thewissen M, Menheere P, Damoiseaux J, Hupperts R.

Mult Scler. 2014 Apr;20(4):433-7. doi: 10.1177/1352458513500552. Epub 2013 Aug 19.

PMID:
23959712
6.

Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.

Peelen E, Thewissen M, Knippenberg S, Smolders J, Muris AH, Menheere P, Tervaert JW, Hupperts R, Damoiseaux J.

J Neuroimmunol. 2013 May 15;258(1-2):77-84. doi: 10.1016/j.jneuroim.2013.02.014. Epub 2013 Mar 19.

7.

Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria.

Peelen E, Rijkers G, Meerveld-Eggink A, Meijvis S, Vogt M, Cohen Tervaert JW, Hupperts R, Damoiseaux J.

Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):61-9. doi: 10.1007/s10096-012-1714-7. Epub 2012 Aug 9.

PMID:
22875191
8.

Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.

Peelen E, Damoiseaux J, Smolders J, Knippenberg S, Menheere P, Tervaert JW, Hupperts R, Thewissen M.

J Neuroimmunol. 2011 Dec 15;240-241:97-103. doi: 10.1016/j.jneuroim.2011.09.013. Epub 2011 Oct 26.

9.

Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission.

Knippenberg S, Peelen E, Smolders J, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J.

J Neuroimmunol. 2011 Oct 28;239(1-2):80-6. doi: 10.1016/j.jneuroim.2011.08.019. Epub 2011 Sep 21.

PMID:
21940055
10.

Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis.

Knippenberg S, Smolders J, Thewissen M, Peelen E, Tervaert JW, Hupperts R, Damoiseaux J.

Mult Scler. 2011 Dec;17(12):1418-23. doi: 10.1177/1352458511412655. Epub 2011 Jun 20.

PMID:
21690147
11.

Effects of vitamin D on the peripheral adaptive immune system: a review.

Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Tervaert JW, Hupperts R, Damoiseaux J.

Autoimmun Rev. 2011 Oct;10(12):733-43. doi: 10.1016/j.autrev.2011.05.002. Epub 2011 May 18. Review.

PMID:
21621002
12.

Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.

Smolders J, Thewissen M, Theunissen R, Peelen E, Knippenberg S, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J.

J Neuroimmunol. 2011 Jun;235(1-2):91-7. doi: 10.1016/j.jneuroim.2011.03.012. Epub 2011 Apr 20.

PMID:
21507492
13.

Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.

Smolders J, Peelen E, Thewissen M, Cohen Tervaert JW, Menheere P, Hupperts R, Damoiseaux J.

PLoS One. 2010 Dec 13;5(12):e15235. doi: 10.1371/journal.pone.0015235.

14.

Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.

Smolders J, Menheere P, Thewissen M, Peelen E, Tervaert JW, Hupperts R, Damoiseaux J.

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):243-6. doi: 10.1016/j.jsbmb.2010.03.001. Epub 2010 Mar 6.

PMID:
20211254
15.

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.

Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J, Hupperts R.

PLoS One. 2009 Aug 13;4(8):e6635. doi: 10.1371/journal.pone.0006635.

16.

The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis.

Smolders J, Peelen E, Thewissen M, Menheere P, Tervaert JW, Hupperts R, Damoiseaux J.

Autoimmun Rev. 2009 Jun;8(7):621-6. doi: 10.1016/j.autrev.2009.02.009. Epub 2009 Feb 11. Review.

PMID:
19393206

Supplemental Content

Loading ...
Support Center